The study of the Genedrive CYP2C19 ID Kit recruited donor specimens (no further information provided), and the GMEX system study recruited healthy people and people with cardiovascular and cerebrovascular diseases. This evidence concerns the gene CYP2C19 and cerebrovascular disorder.